{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:47:26Z","timestamp":1793450846960,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08HL122528-01A1-NIH\/NHLBI"],"award-info":[{"award-number":["K08HL122528-01A1-NIH\/NHLBI"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL157414-01-NIH"],"award-info":[{"award-number":["R01HL157414-01-NIH"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1053\/j.jvca.2024.04.006","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T22:58:19Z","timestamp":1712357899000},"page":"1885-1896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of C-reactive Protein on Anticoagulation Monitoring in Extracorporeal Membrane Oxygenation"],"prefix":"10.1053","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3567-4465","authenticated-orcid":false,"given":"Jai","family":"Madhok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4243-243X","authenticated-orcid":false,"given":"Christian","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9435-2944","authenticated-orcid":false,"given":"Clark G.","family":"Owyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3808-3273","authenticated-orcid":false,"given":"Raymond A.","family":"Pashun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4545-1273","authenticated-orcid":false,"given":"Yasuhiro","family":"Shudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McNulty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaine","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Ruoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya K.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Zehnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe L.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2024.04.006_bib0001","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MAT.0000000000001652","article-title":"2021 ELSO adult and pediatric anticoagulation guidelines","volume":"68","author":"McMichael","year":"2022","journal-title":"ASAIO J-"},{"key":"10.1053\/j.jvca.2024.04.006_bib0002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13054-020-2726-9","article-title":"Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO","volume":"24","author":"Chlebowski","year":"2020","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.04.006_bib0003","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s13054-020-03145-5","article-title":"Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO","volume":"24","author":"Honore","year":"2020","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.04.006_bib0004","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00134-021-06593-x","article-title":"Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: An ELSO registry analysis","volume":"48","author":"Nunez","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2024.04.006_bib0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13054-021-03554-0","article-title":"Anti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): A multicenter cohort study","volume":"25","author":"Descamps","year":"2021","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.04.006_bib0006","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.athoracsur.2020.02.011","article-title":"Feasibility of venovenous extracorporeal membrane oxygenation without systemic anticoagulation","volume":"110","author":"Kurihara","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2024.04.006_bib0007","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MAT.0000000000001216","article-title":"Extracorporeal life support in hemorrhagic conditions: A systematic review","volume":"67","author":"Willers","year":"2020","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2024.04.006_bib0008","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MAT.0000000000001652","article-title":"2021 ELSO adult and pediatric anticoagulation guidelines","volume":"68","author":"McMichael","year":"2022","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2024.04.006_bib0009","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MAT.0000000000001230","article-title":"Thrombosis and bleeding in extracorporeal membrane oxygenation (ECMO) without anticoagulation: A systematic review","volume":"67","author":"Olson","year":"2021","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2024.04.006_bib0010","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/ALN.0000000000003044","article-title":"Anticoagulation management and antithrombin supplementation practice during veno-venous extracorporeal membrane oxygenation: A worldwide survey","volume":"132","author":"Protti","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2024.04.006_bib0011","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/ajcp\/67.5.477","article-title":"Variation among commercial activated partial thromboplastin time reagents in response to heparin","volume":"67","author":"Shapiro","year":"1977","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.jvca.2024.04.006_bib0012","first-page":"782","article-title":"College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: Laboratory monitoring of unfractionated heparin therapy","volume":"122","author":"Olson","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.jvca.2024.04.006_bib0013","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1345\/aph.1R635","article-title":"Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin","volume":"47","author":"Price","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.jvca.2024.04.006_bib0014","first-page":"5","article-title":"ECMO and anticoagulation: A comprehensive review","volume":"26","author":"Mulder","year":"2018","journal-title":"Netherlands Journal of Critical Care"},{"key":"10.1053\/j.jvca.2024.04.006_bib0015","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1213\/ANE.0000000000000115","article-title":"Extracorporeal membrane oxygenation in the adult: A review of anticoagulation monitoring and transfusion","volume":"118","author":"Esper","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2024.04.006_bib0016","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.5858\/arpa.2013-0572-OA","article-title":"The influence of free hemoglobin and bilirubin on heparin monitoring by activated partial thromboplastin time and anti-Xa assay","volume":"138","author":"Kostousov","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.jvca.2024.04.006_bib0017","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2011.08990.x","article-title":"False prolongation of the activated partial thromboplastin time (aPTT) in inflammatory patients: Interference of C-reactive protein","volume":"157","author":"van Rossum","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1053\/j.jvca.2024.04.006_bib0018","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1515\/cclm-2014-0906","article-title":"Interference of C-reactive protein with clotting times","volume":"53","author":"Devreese","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"10.1053\/j.jvca.2024.04.006_bib0019","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjh.15013","article-title":"Inter-individual variability in phospholipid-dependent interference of C-reactive protein on activated partial thromboplastin time","volume":"183","author":"Erdem-Eraslan","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1053\/j.jvca.2024.04.006_bib0020","doi-asserted-by":"crossref","first-page":"e22571","DOI":"10.1002\/jcla.22571","article-title":"The analysis of false prolongation of the activated partial thromboplastin time (activator: silica): Interference of C-reactive protein","volume":"32","author":"Liu","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"10.1053\/j.jvca.2024.04.006_bib0021","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1309\/AJCP3J1ZKYBFQXJM","article-title":"Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization","volume":"137","author":"Fritsma","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.jvca.2024.04.006_bib0022","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jtcvs.2012.01.005","article-title":"Diagnosis of infection in patients undergoing extracorporeal membrane oxygenation: A case-control study","volume":"143","author":"Pieri","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2024.04.006_bib0023","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ejcts\/ezs524","article-title":"Diagnosis of infection in paediatric veno-arterial cardiac extracorporeal membrane oxygenation: Role of procalcitonin and C-reactive protein","volume":"43","author":"Rungatscher","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2024.04.006_bib0024","doi-asserted-by":"crossref","first-page":"e0999","DOI":"10.1097\/CCE.0000000000000999","volume":"5","author":"Aubron","year":"2023","journal-title":"Crit Care Explor"},{"key":"10.1053\/j.jvca.2024.04.006_bib0025","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/jcpt.12415","article-title":"Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study","volume":"41","author":"Samuel","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"10.1053\/j.jvca.2024.04.006_bib0026","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1309\/LM9NJGW2ZIOLPHY6","article-title":"Laboratory monitoring of heparin therapy: Partial thromboplastin time or anti-Xa assay?","volume":"40","author":"Lehman","year":"2009","journal-title":"Lab Med"},{"key":"10.1053\/j.jvca.2024.04.006_bib0027","unstructured":"Brandt JT. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: Introduction. Arch Pathol Lab Med ;122:765-6."},{"key":"10.1053\/j.jvca.2024.04.006_bib0028","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/CCM.0000000000004590","article-title":"A randomized controlled trial of antithrombin supplementation during extracorporeal membrane oxygenation","volume":"48","author":"Panigada","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2024.04.006_bib0029","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3949\/ccjm.86a.18029","article-title":"Anti-Xa assays: What is their role today in antithrombotic therapy?","volume":"86","author":"Hutt Centeno","year":"2019","journal-title":"Cleve Clin J Med"},{"key":"10.1053\/j.jvca.2024.04.006_bib0030","doi-asserted-by":"crossref","first-page":"e7976","DOI":"10.1097\/MD.0000000000007976","article-title":"The effects of hemolysis on plasma prothrombin time and activated partial thromboplastin time tests using photo-optical method","volume":"96","author":"Hernaningsih","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.jvca.2024.04.006_bib0031","first-page":"6","article-title":"ECMO and anticoagulation: A comprehensive review","volume":"26","author":"Marcel","year":"2018","journal-title":"Netherlands Journal of Critical Care"},{"key":"10.1053\/j.jvca.2024.04.006_bib0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13613-017-0352-8","article-title":"Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: A safety and feasibility pilot study","volume":"8","author":"Panigada","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1053\/j.jvca.2024.04.006_bib0033","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MAT.0000000000001004","article-title":"Evaluation of anti-Xa and activated partial thromboplastin time monitoring of heparin in adult patients receiving extracorporeal membrane oxygenation support","volume":"66","author":"Arnouk","year":"2020","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2024.04.006_bib0034","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcrc.2017.02.014","article-title":"Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis","volume":"39","author":"Sy","year":"2017","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2024.04.006_bib0035","first-page":"180","article-title":"Pairwise testing: A best practice that isn't","author":"Bach","year":"2004","journal-title":"Citeseer"},{"key":"10.1053\/j.jvca.2024.04.006_bib0036","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0267659120952982","article-title":"Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: A systematic review and meta-analysis","volume":"36","author":"Willems","year":"2021","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2024.04.006_bib0037","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13054-021-03581-x","article-title":"Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: A propensity-score matched study","volume":"25","author":"Fisser","year":"2021","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.04.006_bib0038","first-page":"383","article-title":"Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass","volume":"96","author":"Koster","year":"2003","journal-title":"Anesth Analg"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307702400243X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307702400243X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T15:18:23Z","timestamp":1728314303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105307702400243X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S105307702400243X"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2024.04.006","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of C-reactive Protein on Anticoagulation Monitoring in Extracorporeal Membrane Oxygenation","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2024.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}